Catalyst Pharmaceuticals (CPRX) News Today $23.23 +0.43 (+1.89%) Closing price 04:00 PM EasternExtended Trading$23.15 -0.08 (-0.34%) As of 06:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period LSV Asset Management Cuts Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)LSV Asset Management decreased its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 18.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 777,124 shares of the biopharmaceutical company's stock after selling 174,2April 15 at 5:54 AM | marketbeat.comFederated Hermes Inc. Purchases 120,249 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Federated Hermes Inc. boosted its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 222.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 174,390 shApril 15 at 4:48 AM | marketbeat.comNorges Bank Invests $1.92 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Norges Bank purchased a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 91,770 shares of the biopharmaceutical coApril 14 at 3:31 AM | marketbeat.comJPMorgan Chase & Co. Has $15.36 Million Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)JPMorgan Chase & Co. grew its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 80.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 736,197 shares of the biopharmaceutical company's stock after acquiring an adApril 14 at 3:29 AM | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Purchased by Martingale Asset Management L PMartingale Asset Management L P raised its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 27.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 110,967 shares of the biopharmaceutical company's stock afApril 13 at 6:08 AM | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Consensus Rating of "Buy" by AnalystsShares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Get Free Report) have been given a consensus recommendation of "Buy" by the eight ratings firms that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating and one has given aApril 13 at 3:13 AM | marketbeat.comKennedy Capital Management LLC Sells 23,750 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Kennedy Capital Management LLC decreased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 2.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,017,666 shares of the biophApril 12 at 8:54 AM | marketbeat.comRenaissance Technologies LLC Increases Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Renaissance Technologies LLC grew its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 7.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,706,116 shares of the biopharmaceApril 12 at 6:29 AM | marketbeat.comIs Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?April 11, 2025 | insidermonkey.comRenaissance Group LLC Invests $4.23 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Renaissance Group LLC bought a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 202,760 shares of the biopharmaceutical company's stockApril 10, 2025 | marketbeat.comCatalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% DipApril 9, 2025 | finance.yahoo.comCatalyst Pharmaceuticals submits NDS to Health Canada for AgamreeApril 9, 2025 | markets.businessinsider.comCatalyst Pharmaceuticals announces Health Canada’s acceptance of AGAMREE NDSApril 9, 2025 | markets.businessinsider.comCatalyst Pharmaceuticals Announces Health Canada's Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye PharmaceuticalsApril 8, 2025 | globenewswire.comVanguard Group Inc. Grows Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Vanguard Group Inc. lifted its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 4.9% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 8,431,094 shares of the biopharmaceutical company's stock after acquiring an additiApril 8, 2025 | marketbeat.comAmerican Century Companies Inc. Grows Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)American Century Companies Inc. boosted its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 18.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 157,409 shares of the biopharmaceutApril 8, 2025 | marketbeat.comTrexquant Investment LP Sells 89,171 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Trexquant Investment LP reduced its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 30.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 206,489 shares of the biopharmaceutApril 7, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Purchases 396,506 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Arrowstreet Capital Limited Partnership increased its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 131.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 698,152 sharApril 6, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by Sei Investments Co.Sei Investments Co. grew its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 14.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 116,318 shares of the biopharmaceutical compaApril 6, 2025 | marketbeat.comBryce Point Capital LLC Purchases Shares of 54,358 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Bryce Point Capital LLC acquired a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 54,358 shares of the biopharmaceutical company's stoApril 5, 2025 | marketbeat.comWhat Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?April 4, 2025 | finance.yahoo.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by Commonwealth Equity Services LLCCommonwealth Equity Services LLC increased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 133.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,331 shares of the bApril 4, 2025 | marketbeat.comWhy a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on ThursdayApril 3, 2025 | fool.comKLP Kapitalforvaltning AS Invests $772,000 in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)KLP Kapitalforvaltning AS bought a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 37,000 shares of the biopharmaceutical compApril 2, 2025 | marketbeat.comCornercap Investment Counsel Inc. Takes $494,000 Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Cornercap Investment Counsel Inc. bought a new position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 23,683 shares of the biopharmaceutical company's stock, valued at approxiMarch 31, 2025 | marketbeat.comHorizon Investment Services LLC Acquires 24,724 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Horizon Investment Services LLC increased its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 167.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 39,524 shares of the biopharmaceutical coMarch 30, 2025 | marketbeat.comSegall Bryant & Hamill LLC Increases Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Segall Bryant & Hamill LLC grew its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 97.8% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 80,354 shares of the biopharmaceutical company's stock after buying an additional 39,721 shareMarch 30, 2025 | marketbeat.comPrudential Financial Inc. Raises Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Prudential Financial Inc. boosted its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 30.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 553,424 shares of the biopharmaceutical company's stock after buying an additional 128,5March 30, 2025 | marketbeat.comJim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’March 27, 2025 | msn.comCibc World Markets Corp Acquires Shares of 10,463 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Cibc World Markets Corp bought a new position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 10,463 shares of the biopharmaceutical company's stock, valued at approximately $218,0March 27, 2025 | marketbeat.comNatixis Advisors LLC Buys 13,616 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Natixis Advisors LLC boosted its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 29.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 59,253 shares of the biopharmaceutical company's stMarch 26, 2025 | marketbeat.comWith 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the businessMarch 26, 2025 | finance.yahoo.comProficio Capital Partners LLC Acquires New Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Proficio Capital Partners LLC bought a new position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 16,258 shares of the biopharmaceuticalMarch 26, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Reaches New 12-Month High - What's Next?Catalyst Pharmaceuticals (NASDAQ:CPRX) Reaches New 52-Week High - Here's WhyMarch 25, 2025 | marketbeat.comAdvantage Alpha Capital Partners LP Has $272,000 Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Advantage Alpha Capital Partners LP lessened its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 48.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 13,050 shares of the biopharmaceutical company's stock after selling 12,March 25, 2025 | marketbeat.comRaymond James Financial Inc. Invests $6.89 Million in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Raymond James Financial Inc. acquired a new stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 329,980 shares of the biopharmaceuticalMarch 24, 2025 | marketbeat.comZacks Research Has Negative Outlook of CPRX FY2025 EarningsCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) - Equities researchers at Zacks Research reduced their FY2025 earnings estimates for Catalyst Pharmaceuticals in a research report issued on Wednesday, March 19th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceuticMarch 24, 2025 | marketbeat.comIntech Investment Management LLC Raises Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Intech Investment Management LLC raised its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 103.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 65,826 shares of the biopharmaceutical company's stoMarch 23, 2025 | marketbeat.comCatalyst Pharmaceuticals (NASDAQ:CPRX) Shares Up 1.9% - Here's WhyCatalyst Pharmaceuticals (NASDAQ:CPRX) Shares Up 1.9% - Here's WhyMarch 22, 2025 | marketbeat.comZacks Research Brokers Raise Earnings Estimates for CPRXCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) - Zacks Research upped their Q1 2025 earnings estimates for Catalyst Pharmaceuticals in a research report issued to clients and investors on Wednesday, March 19th. Zacks Research analyst A. Chakraborty now expects that the biopharmaceuticMarch 22, 2025 | marketbeat.comAdvisors Asset Management Inc. Has $3.47 Million Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Advisors Asset Management Inc. cut its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 6.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 166,047 shares of the biopharmaceutical companyMarch 22, 2025 | marketbeat.comBoston Partners Purchases 16,601 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Boston Partners lifted its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 1.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,291,868 shares of the biopharmaceutical company's stock after purchasing an additionalMarch 21, 2025 | marketbeat.comAmundi Has $1.29 Million Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Amundi raised its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 188.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 56,609 shares of the biopharmaceutical company's stock after buyingMarch 19, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. increased its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 6.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,246,925 shares ofMarch 18, 2025 | marketbeat.comRoyce & Associates LP Trims Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Royce & Associates LP lowered its stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 7.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,864,351 shares of the biopharmaceutical companyMarch 17, 2025 | marketbeat.comVestcor Inc Reduces Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Vestcor Inc lessened its holdings in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 53.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,865 shares of the biopharmaMarch 17, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Recommendation of "Buy" by AnalystsShares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Get Free Report) have been given an average rating of "Buy" by the nine research firms that are presently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy rating and one has assigned a sMarch 17, 2025 | marketbeat.comUS Bancorp DE Has $130,000 Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)US Bancorp DE decreased its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 86.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,223 shares of the biopharmaceutical company's stock after selliMarch 17, 2025 | marketbeat.comGlobeflex Capital L P Has $4.07 Million Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)Globeflex Capital L P grew its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 319.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 194,786 shares of the biopharmaceutical company's stock after buying an additional 148,388 shares duriMarch 16, 2025 | marketbeat.comCatalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stock Position Increased by Skandinaviska Enskilda Banken AB publSkandinaviska Enskilda Banken AB publ boosted its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 74.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 731,900 shares of the biopharmacMarch 15, 2025 | marketbeat.com Remove Ads Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPRX Media Mentions By Week CPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPRX News Sentiment▼1.320.80▲Average Medical News Sentiment CPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPRX Articles This Week▼146▲CPRX Articles Average Week Remove Ads Get Catalyst Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RDY News MRNA News ASND News QGEN News VTRS News ROIV News LNTH News RVMD News BBIO News TGTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CPRX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Catalyst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Catalyst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CPRX Stock Free CPRX Stock Alerts